Showing results (1761-1770 of 1,881) with videos related to

Sort By:
Pageof 189
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2022
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated VaccineNancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Journal of Clinical Microbiology|November 3, 2020
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster SeraRanawaka A P M Perera, Ronald Ko, Owen T Y Tsang, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Plos One|November 24, 2025
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United StatesShelby S Fisher, Arnstein Lindaas, Stella G Muthuri, et al.
Nature Communications|April 27, 2023
Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong KongRuopeng Xie, Kimberly M Edwards, Dillon C Adam, et al.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Nature Medicine|March 18, 2026
Mass azithromycin distribution and antibiotic resistance in the gut and nasopharynx: a cluster-randomized trialThuy Doan, Daisy Yan, Ahmed M Arzika, et al.
Nature Communications|May 26, 2022
SARS-CoV-2 accessory proteins reveal distinct serological signatures in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Cell Reports|April 27, 2017
Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma ProgressionPetko Fiziev, Kadir C Akdemir, John P Miller, et al.
Circulation|November 23, 2020
RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in MiceDenuja Karunakaran, My-Anh Nguyen, Michele Geoffrion, et al.
Pageof 189